$BIAF
BioAffinity Technologies announcing that sales of their CyPath® Lung cancer diagnostic test in Q1 2026 beat expectations with 146% growth vs. the prior year.
$RMSG
Real Messenger (RMSG) received a Nasdaq notification on April 8, 2026, for failing the minimum $2.5 million stockholders’ equity requirement (currently at $1.11 million) and now has until May 21 to submit a compliance plan to avoid potential delisting.
$CYCN
BUZZ Cyclerion surges on its all stock merger with Korsana Biosciences and $380M funding commitment.
$AIXI
China's Supreme Court upheld XiaoI's AI patents in its Apple infringement case.
$BCG
Binah Capital delivered strong FY25 results $2.3M net income and revenue up 10.8% to $187.1M.
$VRAX
They appear to have used an electronic QMS platform (Trackmedium) to help implement and maintain the processes leading to certification.
$BFRG
Market up (Dow +200), and Bullfrog AI stock is surging.
Several companies are set to list in late March and April 2026, mostly at $4–$10 offering prices. Notable ones include:
QDRU (QDRO Acquisition) on 03/27/2026 at $10.00
BCACU (Brookline Capital) on 03/30/2026 at $10.00
HMH (HMH Holding) on 04/01/2026 priced $19–22
AXTN (Akston Biosciences) on 04/01/2026 at $8–10
SEAH (Seahawk Recycling) on 04/02/2026 at $4–6
Most are small to mid size offerings with shares ranging from 1M to 20M.
$BUR
The linked press release from Burford Capital (dated March 27, 2026) is a statement reacting to a U.S. Court of Appeals for the Second Circuit decision in the long running YPF case (involving claims by Petersen and Eton Park against Argentina and YPF, which Burford has funded).
$CCHH
Neutral to Slightly Negative the company is reporting results with a net loss for the first half of 2025 and fulfilling reporting requirements, which aren’t inherently positive catalysts.
$ICON
Negativ
Neutral to slight negative in sentiment it typically signals the company is addressing low share price or reporting compliance, not necessarily strong growth.
$IVF
8K Negative (short term).
Neutral at best long-term unless a real catalyst appears.
New CFO = damage control, not growth dilution risk stays, fade the hype until real catalyst.
$LOVA
Iovance issued stock options covering 43,150 shares to four new non executive employees under a NASDAQ inducement rule, aimed at helping the company attract and retain talent as its biotech operations grow.
$RKLB
Rocket Lab ended 2025 on a high note with 21 successful Electron launches, all meeting mission objectives, and reinforced its role as a key launch provider for commercial and government space projects particularly for iQPS’s Earth-imaging satellite constellation.
$ASTS
My Analys
Good Buy Entry
Aggressive Entry: Near the current level $85.60, anticipating a bounce from this support area.
Conservative Entry: Wait for a confirmed breakout above $87.11 with strong volume, signaling the short-term downtrend has reversed.
Sell Exit / Stop Loss
Take Profit: Start scaling out of the position in the $93.50 - $97.00 range.
Stop Loss: Place a stop loss at $84.50 or just below. A break below the day's low of $84.65 would be a negative signal, suggesting a retest of lower support levels.
$SGBX
The stock is showing signs of weakness. The price trading below key moving averages and a bearish RSI suggest the potential for further downward movement, possibly testing the support level near the day's low of 4.030 or the longer-term EMA at 3.974. A break above 4.310 would be needed to invalidate this bearish near term view.
$CREV is consolidating above EMA20 at 5.02 after a strong breakout from 3.64; as long as it holds above 5.00, the next upside targets are 5.75, 6.79, and 8.74 with bullish momentum building.
$ARTV is consolidating above EMA20 after a strong rally; as long as it holds above 5.45, the next targets are 6.39 and 6.85, with a breakout potential toward 7.20–7.35.
Watch out these 8 stocks for the next move..
$AKAN (Akanda Corp): $3.750, +68.16%, Volume: 3.64M, Market Cap: $1.62M
$KZR (Kezar Life Sciences): $6.00, +43.77%, Volume: 1.42M, Market Cap: $30.54M
$KMKR (K-Tech Solutions): $1.860, +28.27%, Volume: 6.67M, Market Cap: $31.18M
$FEMY (Femasys Inc): $0.9590, +28.66%, Volume: 84.35M, Market Cap: $32.06M
$XBP (XBP Global Holdings): $0.5675, +10.67%, Volume: 289.70K, Market Cap: $60.26M
$EGAN (Egain Corp): $15.00, +8.23%, Volume: 437.85K, Market Cap: $372.38M
$THM (International Tower Hill Mines)
$ARTV (Artiva Biotherapeutics): $5.37, +93.90%, Volume: 11.57M, Market Cap: $67.66M
Date: 2025-10-16
$AKAN
The recent surge and high RSI suggest potential short-term bullish momentum, but the overbought condition warns of a possible reversal. No specific price targets are derivable from this chart alone
The strong upward move and high RSI suggest short-term bullish momentum, but the overbought RSI warns of a potential pullback.
